Ignite Creation Date:
2024-05-06 @ 7:32 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02558387
Status:
UNKNOWN
Last Update Posted:
2015-11-20
First Post:
2015-09-22
Brief Title:
Trial of BIBF1120 Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Organization Data
Organization:
Samsung Medical Center
Class:
OTHER
Study ID:
2013-120133
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Samsung Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Myung-Ju Ahn
Responsible Party Title:
MD PhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Samsung Medical Center
Old Name:
None
Old Organization:
None